EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in management of Graves’ disease: an update

Shailendra Kumar Singh iD, Rina Singh, Arun Kumar Pandey, Vanshika Singh, Alankar Tiwari, Pradeep Kumar Rai

Postgraduate Medical Journal · 17.03.2026 · 102 (1206) · 302-310

DOI: 10.1093/postmj/qgaf197 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Postgraduate Medical Journal, online erschienen am 19.11.2025. Verfasst von Shailendra Kumar Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine, Endocrine Clinic, Gilat Bazar, Varanasi, Uttar Pradesh, 221002, India. Hauptthemen laut MEDLINE: Graves Disease, Antithyroid Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of Graves’ disease (GD) is complex and controversial. Conventional therapy of GD includes antithyroid drugs (ATDs), surgery, and radio-iodine therapy (RIT) and each has limitations. ATDs are associated with high rates of relapse and side effects. Definitive therapies result in permanent hypothyroidism and increased risk of Graves’ ophthalmopathy. With advancements in the understanding of precise autoimmune mechanisms causing GD, novel therapies targeting immune pathways are in the pipeline of development. Newer drugs switch off a part of the immune system that is causing the disease, leaving the rest of the immune system still functioning. Though newer drugs seem to be efficacious, they may elicit higher incidence of infection and other side effects. Other concerns with newer drugs are that they may not be able to cure the disease, do not achieve adequate effectiveness in all patients, and may not achieve remission in all patients. Therefore, additional newer drugs will be needed in future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseAntithyroid AgentsHumansIodine RadioisotopesThyroidectomyGraves Ophthalmopathy

Stichwörter der Autor:innen

Graves’ diseasehyperthyroidismmonoclonal antibodynewer treatment

Substanzen

Antithyroid AgentsIodine Radioisotopes

Autor:innen und Institutionen

  • Department of Endocrine, Endocrine Clinic, Gilat Bazar, Varanasi, Uttar Pradesh, 221002, India.
  • Department of Endocrinology, Lucknow Endocrine Diabetes and Thyroid Clinic, 2/1 Vivek Khand, Gomtinagar, Lucknow, Uttar Pradesh, 226010, India.
  • Department of Internal Medicine, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India.
  • Department of Endocrine, Diabetes and Endocrine Care Superspeciality Clinic, Varanasi, Uttar Pradesh, 221005, India.
  • Department of Nephrology, Opal Hospital, Varanasi, Uttar Pradesh, 221006, India.

ORCID-Profile: Shailendra Kumar Singh

Zitieren

APA

Singh, S. K., Singh, R., Pandey, A. K., Singh, V., Tiwari, A., & Rai, P. K. (2026). Recent advances in management of Graves’ disease: an update. Postgraduate Medical Journal, 102(1206), 302-310. https://doi.org/10.1093/postmj/qgaf197

Vancouver

Singh SK, Singh R, Pandey AK, Singh V, Tiwari A, Rai PK. Recent advances in management of Graves’ disease: an update. Postgraduate Medical Journal. 2026;102(1206):302-310. doi:10.1093/postmj/qgaf197

BibTeX
@article{Singh2026,
  author = {Singh, Shailendra Kumar and Singh, Rina and Pandey, Arun Kumar and Singh, Vanshika and Tiwari, Alankar and Rai, Pradeep Kumar},
  title = {Recent advances in management of Graves’ disease: an update},
  journal = {Postgraduate Medical Journal},
  year = {2026},
  volume = {102},
  number = {1206},
  pages = {302--310},
  doi = {10.1093/postmj/qgaf197}
}
Kostenlos starten →